JPS60243026A - モノクロ−ナル抗体 - Google Patents
モノクロ−ナル抗体Info
- Publication number
- JPS60243026A JPS60243026A JP59097549A JP9754984A JPS60243026A JP S60243026 A JPS60243026 A JP S60243026A JP 59097549 A JP59097549 A JP 59097549A JP 9754984 A JP9754984 A JP 9754984A JP S60243026 A JPS60243026 A JP S60243026A
- Authority
- JP
- Japan
- Prior art keywords
- human
- cancer
- monoclonal antibody
- epithelium
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000005718 Stomach Neoplasms Diseases 0.000 claims abstract description 24
- 206010017758 gastric cancer Diseases 0.000 claims abstract description 24
- 201000011549 stomach cancer Diseases 0.000 claims abstract description 24
- 239000000427 antigen Substances 0.000 claims abstract description 21
- 102000036639 antigens Human genes 0.000 claims abstract description 21
- 108091007433 antigens Proteins 0.000 claims abstract description 21
- 210000000981 epithelium Anatomy 0.000 claims abstract description 21
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims abstract description 11
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims abstract description 11
- 201000002528 pancreatic cancer Diseases 0.000 claims abstract description 11
- 208000008443 pancreatic carcinoma Diseases 0.000 claims abstract description 11
- 206010009944 Colon cancer Diseases 0.000 claims abstract description 9
- 206010006187 Breast cancer Diseases 0.000 claims abstract description 7
- 208000026310 Breast neoplasm Diseases 0.000 claims abstract description 7
- 210000000013 bile duct Anatomy 0.000 claims abstract description 7
- 208000029742 colonic neoplasm Diseases 0.000 claims abstract description 7
- 210000004379 membrane Anatomy 0.000 claims abstract description 7
- 239000012528 membrane Substances 0.000 claims abstract description 7
- 210000000277 pancreatic duct Anatomy 0.000 claims abstract description 7
- 210000002307 prostate Anatomy 0.000 claims abstract description 7
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims abstract description 6
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims abstract description 6
- 208000002495 Uterine Neoplasms Diseases 0.000 claims abstract description 6
- 208000006990 cholangiocarcinoma Diseases 0.000 claims abstract description 6
- 230000002183 duodenal effect Effects 0.000 claims abstract description 6
- 201000004101 esophageal cancer Diseases 0.000 claims abstract description 6
- 210000001156 gastric mucosa Anatomy 0.000 claims abstract description 6
- 210000003494 hepatocyte Anatomy 0.000 claims abstract description 6
- 208000020816 lung neoplasm Diseases 0.000 claims abstract description 6
- 206010046766 uterine cancer Diseases 0.000 claims abstract description 6
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 claims abstract description 5
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 claims abstract description 5
- 210000001913 submandibular gland Anatomy 0.000 claims abstract description 5
- 108090000288 Glycoproteins Proteins 0.000 claims abstract description 4
- 102000003886 Glycoproteins Human genes 0.000 claims abstract description 4
- 230000000968 intestinal effect Effects 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 18
- 230000000890 antigenic effect Effects 0.000 claims description 10
- 206010004593 Bile duct cancer Diseases 0.000 claims description 5
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 5
- 208000026900 bile duct neoplasm Diseases 0.000 claims description 5
- 238000002523 gelfiltration Methods 0.000 claims description 5
- 201000005202 lung cancer Diseases 0.000 claims description 5
- 210000004027 cell Anatomy 0.000 abstract description 45
- 206010028980 Neoplasm Diseases 0.000 abstract description 36
- 201000011510 cancer Diseases 0.000 abstract description 27
- 206010035226 Plasma cell myeloma Diseases 0.000 abstract description 9
- 201000000050 myeloid neoplasm Diseases 0.000 abstract description 9
- 241001465754 Metazoa Species 0.000 abstract description 8
- 230000009257 reactivity Effects 0.000 abstract description 8
- 210000000628 antibody-producing cell Anatomy 0.000 abstract description 7
- 210000004907 gland Anatomy 0.000 abstract description 7
- 125000000837 carbohydrate group Chemical group 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 210000000496 pancreas Anatomy 0.000 abstract 1
- 210000005239 tubule Anatomy 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 description 31
- 210000002966 serum Anatomy 0.000 description 19
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 10
- 210000004408 hybridoma Anatomy 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 6
- 238000010186 staining Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- 210000003719 b-lymphocyte Anatomy 0.000 description 4
- 230000007910 cell fusion Effects 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 210000004877 mucosa Anatomy 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 239000003760 tallow Substances 0.000 description 4
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 3
- 108060003951 Immunoglobulin Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 208000009956 adenocarcinoma Diseases 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000003113 dilution method Methods 0.000 description 3
- 102000018358 immunoglobulin Human genes 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 238000011580 nude mouse model Methods 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 206010054949 Metaplasia Diseases 0.000 description 2
- 102000005348 Neuraminidase Human genes 0.000 description 2
- 108010006232 Neuraminidase Proteins 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000016784 immunoglobulin production Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000007500 overflow downdraw method Methods 0.000 description 2
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- LCTORNIWLGOBPB-GASJEMHNSA-N (3r,4s,5s,6r)-2-amino-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound NC1(O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O LCTORNIWLGOBPB-GASJEMHNSA-N 0.000 description 1
- TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 1
- 208000010507 Adenocarcinoma of Lung Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000699660 Mus musculus Species 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 208000003252 Signet Ring Cell Carcinoma Diseases 0.000 description 1
- 206010041067 Small cell lung cancer Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229960003896 aminopterin Drugs 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 238000011717 athymic nude mouse Methods 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 238000003163 cell fusion method Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000001728 clone cell Anatomy 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 201000005249 lung adenocarcinoma Diseases 0.000 description 1
- 201000009546 lung large cell carcinoma Diseases 0.000 description 1
- 201000005243 lung squamous cell carcinoma Diseases 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 210000003200 peritoneal cavity Anatomy 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 125000005629 sialic acid group Chemical group 0.000 description 1
- 201000008123 signet ring cell adenocarcinoma Diseases 0.000 description 1
- 208000000587 small cell lung carcinoma Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 210000003699 striated muscle Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002992 thymic effect Effects 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59097549A JPS60243026A (ja) | 1984-05-17 | 1984-05-17 | モノクロ−ナル抗体 |
| US06/732,406 US4683200A (en) | 1984-05-17 | 1985-05-09 | Monoclonal antibody to human cancer antigen and method for producing same |
| KR1019850003312A KR930003912B1 (ko) | 1984-05-17 | 1985-05-15 | 모노클로날 항체 및 제조방법 |
| DE8585303481T DE3586440T2 (de) | 1984-05-17 | 1985-05-17 | Zur diagnose von menschlichem magen- oder brustkrebs zu verwendender monoklonaler antikoerper. |
| EP85303481A EP0161941B1 (en) | 1984-05-17 | 1985-05-17 | Monoclonal antibody useful in the diagnosis of human stomach or breast cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59097549A JPS60243026A (ja) | 1984-05-17 | 1984-05-17 | モノクロ−ナル抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60243026A true JPS60243026A (ja) | 1985-12-03 |
| JPH0152400B2 JPH0152400B2 (enExample) | 1989-11-08 |
Family
ID=14195319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59097549A Granted JPS60243026A (ja) | 1984-05-17 | 1984-05-17 | モノクロ−ナル抗体 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60243026A (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6321562A (ja) * | 1986-07-15 | 1988-01-29 | Kyowa Hakko Kogyo Co Ltd | 抗ヒト胃癌単クロ−ン性抗体ａｍｃ−４６２ |
| JPH0347089A (ja) * | 1989-03-09 | 1991-02-28 | Meiji Seika Kaisha Ltd | 膵癌細胞に対するモノクローナル抗体及び該抗産生ハイブリドーマ |
-
1984
- 1984-05-17 JP JP59097549A patent/JPS60243026A/ja active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6321562A (ja) * | 1986-07-15 | 1988-01-29 | Kyowa Hakko Kogyo Co Ltd | 抗ヒト胃癌単クロ−ン性抗体ａｍｃ−４６２ |
| JPH0347089A (ja) * | 1989-03-09 | 1991-02-28 | Meiji Seika Kaisha Ltd | 膵癌細胞に対するモノクローナル抗体及び該抗産生ハイブリドーマ |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0152400B2 (enExample) | 1989-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4683200A (en) | Monoclonal antibody to human cancer antigen and method for producing same | |
| US8758753B2 (en) | Ganglioside associated recombinant antibodies and the use thereof in the treatment of tumors | |
| EP0252769A2 (en) | Anti-human pulmonary carcinoma monoclonal antibody | |
| JPH0249596A (ja) | ヒト前立腺上皮細胞の表面に特異的に反応するモノクローナル抗体 | |
| PT79894B (en) | Process for preparing tumor specific monoclonal antibodies | |
| US4800155A (en) | Human monoclonal antibody to lung carcinoma and hybridoma producing the same | |
| EP0156578B1 (en) | A process for preparing hybridoma cells which produce tumour specific monoclonal antibodies | |
| EP0154550A2 (en) | Monoclonal antibodies capable of binding to pancreatic carcinoma of ductal origin | |
| AU598447B2 (en) | Monoclonal antibody to human adenocarcinoma cells, and its preparation and use | |
| JPS60243026A (ja) | モノクロ−ナル抗体 | |
| JPS6143200A (ja) | モノクロ−ナル抗体 | |
| JPS6321562A (ja) | 抗ヒト胃癌単クロ−ン性抗体ａｍｃ−４６２ | |
| JPS60190722A (ja) | 抗ヒト肺癌単クロ−ン性抗体 | |
| SUGIYAMA et al. | Preparation of human monoclonal antibodies of IgG type to gastro-intestinal cancer-associated antigen | |
| CN118307677B (zh) | 一种针对间皮素的单克隆抗体及应用 | |
| PT95856B (pt) | Processo para a preparacao de novos anticorpos monoclonais anti-idiotipicos | |
| JPH0145359B2 (enExample) | ||
| WO1997030173A1 (en) | Monoclonal antibody that recognizes antigens present on the surface of endothelial cell of tumor vessel | |
| JPS60178826A (ja) | モノクロ−ナル抗体，その製法及び抗原 | |
| JPS60199830A (ja) | モノクロ−ナル抗体 | |
| JP2743015B2 (ja) | Ｏ―アセチル化されたガングリオシドｇｍ▲下３▼に特異的なモノクローナル抗体、該抗体を産生するハイブリドーマ及びその作製方法 | |
| JPS62212399A (ja) | モノクロ−ナル抗体 | |
| JPS61236798A (ja) | モノクロ−ナル抗体 | |
| JPS62123200A (ja) | モノクロ−ナル抗体 | |
| JPS6349094A (ja) | モノクロ−ナル抗体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |